Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.11.6961

Human Papillomavirus Genotypes and Cervical Cancer in Northeast Thailand  

Natphopsuk, Sitakan (Department of Physiology, Faculty of Public Health, Khon Kaen University)
Settheetham-Ishida, Wannapa (Department of Physiology, Faculty of Public Health, Khon Kaen University)
Pientong, Chamsai (Department of Microbiology, Faculty of Public Health, Khon Kaen University)
Sinawat, Supat (Department of Physiology, Faculty of Public Health, Khon Kaen University)
Yuenyao, Pissamai (Department of Obstetrics and Gynecology, Surin Hospital)
Ishida, Takafumi (Department of Biological Sciences, Graduate School of Science, The University of Tokyo)
Settheetham, Dariwan (Department of Environmental Health, Faculty of Public Health, Khon Kaen University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.11, 2013 , pp. 6961-6964 More about this Journal
Abstract
Human papillomavirus (HPV) is a major cause of cervical cancer. More than 100 HPV genotypes have been identified; however the distribution varies geographically and according to ethnicity. The purpose of this study was to investigate the prevalence and distribution of HPV subtypes among Northeast Thai women. Subjects included 198 cases of SCCA and 198 age-matched, healthy controls. HPV-DNA was amplified by PCR using the consensus primers GP5+/6+ system followed by reverse line blot hybridization genotyping. The prevalence of high-risk HPV infection was 21 (10.1%) and 152 (76.8%) in the controls and in the cases, respectively. High-risk HPV significantly increased the risk for cervical cancer with an OR of 42.4 (95%CI: 22.4-81.4, p<0.001) and an adjusted OR of 40.7-fold (95%CI: 21.5-76.8, p <0.001). HPV-16 was the most prevalent HPV type in the SCCA (56.2%) followed by HPV-58 (17.8%) and HPV-18 (13.6%); whereas HPV-58 (46.4%) was a prominent genotype in the controls followed by HPV-16 (39.3%) and unidentified HPV types (25.0%). These findings indicate that HPV infection remains a critical risk factor for SCCA; particularly, HPV-16, HPV-58 and HPV-18. In order to eradicate cervical cancer, sustained health education, promoted use of prophylactics and a HPV-58 vaccine should be introduced in this region.
Keywords
Cervical cancer; HPV genotype; HPV prevalence; Northeast Thailand;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bhatla N, Lal N, Bao YP, Ng T, Qiao YL (2008). A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine, 26, 2811-7.   DOI   ScienceOn
2 Camargo M, Soto-De Leon S, Sanchez R, et al (2011). Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets. J Virol Methods, 178, 68-74.   DOI   ScienceOn
3 Chan PK, Cheung JL, Cheung TH, et al (2007). HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol, 105, 736-41.   DOI   ScienceOn
4 Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
5 Chichareon S, Herrero R, Munoz N, et al (1998). Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst, 90, 50-7.   DOI   ScienceOn
6 Chinchai T, Chansaenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y (2012). Prevalence of human papillomavirus genotypes in cervical cancer. Int J Gynecol Cancer, 22, 1063-8.   DOI   ScienceOn
7 de Sanjose S, Diaz M, Castellsague X, et al (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 7, 453-9.   DOI   ScienceOn
8 Domingo EJ, Noviani R, Noor MR, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26, 71-9.   DOI   ScienceOn
9 Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.   DOI   ScienceOn
10 Goldsmith DB, West TM, Morton R (2002). HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. Clin Otolaryngol Allied Sci, 27, 61-7.   DOI   ScienceOn
11 Huang LW, Chao SL, Chen PH, Chou HP (2004). Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol, 29, 271-6.   DOI   ScienceOn
12 Huang S, Afonina I, Miller BA, Beckmann AM (1997). Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 70, 408-11.   DOI
13 Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2011). Human papillomavirus genotypes among infected Thai women with different cytological findings by analysis of E1 genes. New Microbiol, 34, 147-56.
14 Kawana K, Adachi K, Kojima S, Kozuma S, Fujii T (2012). Therapeutic Human papillomavirus (HPV) Vaccines: a novel approach. Open Virol J, 6, 264-9.   DOI   ScienceOn
15 Konno R, Shin HR, Kim YT, et al (2008). Human papillomavirus infection and cervical cancer prevention in Japan and Korea. Vaccine, 26, 30-42.
16 Liaw KL, Hildesheim A, Burk RD, et al (2001). A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis, 183, 8-15.   DOI   ScienceOn
17 National Cancer Institute (2012). Hospital-based cancer registry 2011. Bangkok.
18 Romphruk AV, Puapairoj C, Romphruk A, et al (1999). Distributions of HLA-DRB1/DQB1 alleles and haplotypes in the north-eastern Thai population: indicative of a distinct Thai population with Chinese admixtures in the central Thais. Eur J Immunogenet, 26, 129-33.   DOI   ScienceOn
19 Romphruk AV, Romphruk A, Kongmaroeng C, et al (2010). HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens, 75, 701-11.   DOI   ScienceOn
20 Serrano B, Alemany L, Tous S, et al (2012). Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer, 7, 38.   DOI   ScienceOn
21 Sonoda S (1990). Genetic and immunologic determinants of HTLV-I-associated diseases. In human retrovirology: HTLV. New York W.A. Raven Press, Ltd.
22 Settheetham-Ishida W, Kanjanavirojkul N, Kularbkaew C, Ishida T (2005). Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol Immunol, 49, 417-21.   DOI
23 Shi JF, Qiao YL, Smith JS, et al (2008). Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine, 26, 53-9.
24 Siriaunkgul S, Suwiwat S, Settakorn J, et al (2008). HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol, 108, 555-60.   DOI   ScienceOn
25 Sriamporn S, Snijders PJ, Pientong C, et al (2006). Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. Int J Gynecol Cancer, 16, 266-9.   DOI   ScienceOn
26 Sukvirach S, Smith JS, Tunsakul S, et al (2003). Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis, 187, 1246-56.   DOI   ScienceOn
27 Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, et al (2011). Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women. Asian Pac J Cancer Prev, 12, 853-6.
28 Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH (2008). Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Vaccine, 26, 60-70.   DOI   ScienceOn
29 van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al (2002). GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol, 40, 779-87.   DOI   ScienceOn
30 Tungsinmunkong K, Suwiwat S, Sriplung H (2006). Detection of human papillomavirus in intraepithelial lesions and carcinoma of the cervix uteri in southern Thai women. Asian Pac J Cancer Prev, 7, 427-30.
31 Villa LL (2006). Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Vaccine, 24, 23-8.   DOI   ScienceOn
32 Xue Y, Lim D, Zhi L, et al (2012). Loss of HPV16 E2 protein expression without disruption of the E2 ORF correlates with carcinogenic progression. Open Virol J, 6, 163-72.   DOI   ScienceOn
33 Yue Y, Yang H, Wu K, et al (2013). Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China. PLoS One, 8, 55204.   DOI